when was the first glp 1 agonist approved Figure 2, Health Canada Approval Timeline for GLP-1 Receptor Agonists by Marketed Date and NOC Dates - Formulary Management of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists GLP-1 Agonists Market Report 2025-2033,

Codeage GLP-1 Probiotic+ is carefully formulated to meet the needs of individuals with dietary restrictions

Peak GLP-1 increases were significantly higher (~32%) after RYGB at both follow-ups (p<0.05)

Flier, for being an important part of the early discovery work, almost four decades ago.

India Issues Urgent GLP-1 Drug Safety Alert The Indian Pharmacopoeia Commission (IPC) has issued a public notice on 14 May calling on doctors, patients, and consumers to closely monitor and report any adverse reactions linked to semaglutide and other GLP-1 receptor agonists including dulaglutide, liraglutide, and tirzepatide

A Breakthrough Award, New Evidence in Parkinson's and Heart Disease

This study included 41 participants (RYGB: n=21, OAGB: n=20) from the randomized RYSA trial with similar amounts of bypassed intestine between the procedures